These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 25377444)

  • 21. Increased Intrathecal Immune Activation in Virally Suppressed HIV-1 Infected Patients with Neurocognitive Impairment.
    Edén A; Marcotte TD; Heaton RK; Nilsson S; Zetterberg H; Fuchs D; Franklin D; Price RW; Grant I; Letendre SL; Gisslén M
    PLoS One; 2016; 11(6):e0157160. PubMed ID: 27295036
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HIV-associated dementia.
    Major EO; Rausch D; Marra C; Clifford D
    Science; 2000 Apr; 288(5465):440-2. PubMed ID: 10798979
    [No Abstract]   [Full Text] [Related]  

  • 23. Neurocognitive impairment in HIV-infected naïve patients with advanced disease: the role of virus and intrathecal immune activation.
    Airoldi M; Bandera A; Trabattoni D; Tagliabue B; Arosio B; Soria A; Rainone V; Lapadula G; Annoni G; Clerici M; Gori A
    Clin Dev Immunol; 2012; 2012():467154. PubMed ID: 22489249
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intrathecal immune activation is associated with cerebrospinal fluid markers of neuronal destruction in AIDS patients.
    Hagberg L; Fuchs D; Rosengren L; Gisslén M
    J Neuroimmunol; 2000 Jan; 102(1):51-5. PubMed ID: 10626666
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sequence heterogeneity and viral dynamics in cerebrospinal fluid and plasma during antiretroviral therapy.
    Haas DW
    J Neurovirol; 2004; 10 Suppl 1():33-7. PubMed ID: 14982737
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cerebrospinal fluid human immunodeficiency virus type 1 RNA levels are elevated in neurocognitively impaired individuals with acquired immunodeficiency syndrome. HIV Neurobehavioral Research Center Group.
    Ellis RJ; Hsia K; Spector SA; Nelson JA; Heaton RK; Wallace MR; Abramson I; Atkinson JH; Grant I; McCutchan JA
    Ann Neurol; 1997 Nov; 42(5):679-88. PubMed ID: 9392566
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intrathecal viral replication and cerebral deficits in different stages of human immunodeficiency virus disease.
    Arendt G; Nolting T; Frisch C; Husstedt IW; Gregor N; Koutsilieri E; Maschke M; Angerer A; Obermann M; Neuen-Jacob E; Adams O; Loeffert S; Riederer P; ter Meulen V; Sopper S;
    J Neurovirol; 2007 Jun; 13(3):225-32. PubMed ID: 17613712
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HIV encephalitis in a patient on antiretroviral therapy: a case report.
    Hlebowicz M; Parczewski M; Jakubowski P
    Int J STD AIDS; 2019 May; 30(6):617-619. PubMed ID: 30722753
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cerebrospinal fluid biomarkers and HIV-associated neurocognitive disorders in HIV-infected individuals in Rakai, Uganda.
    Abassi M; Morawski BM; Nakigozi G; Nakasujja N; Kong X; Meya DB; Robertson K; Gray R; Wawer MJ; Sacktor N; Boulware DR
    J Neurovirol; 2017 Jun; 23(3):369-375. PubMed ID: 27995575
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combined minocycline plus pyruvate treatment enhances effects of each agent to inhibit inflammation, oxidative damage, and neuronal loss in an excitotoxic animal model of Huntington's disease.
    Ryu JK; Choi HB; McLarnon JG
    Neuroscience; 2006 Sep; 141(4):1835-48. PubMed ID: 16809003
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HIV-associated neurocognitive disorder: pathogenesis and therapeutic opportunities.
    Lindl KA; Marks DR; Kolson DL; Jordan-Sciutto KL
    J Neuroimmune Pharmacol; 2010 Sep; 5(3):294-309. PubMed ID: 20396973
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HIV-1 reverse transcriptase sequence in plasma and cerebrospinal fluid of patients with AIDS dementia complex treated with Abacavir.
    Lanier ER; Sturge G; McClernon D; Brown S; Halman M; Sacktor N; McArthur J; Atkinson JH; Clifford D; Price RW; Simpson D; Torres G; Catalan J; Marder K; Power C; Hall C; Romero C; Brew B
    AIDS; 2001 Apr; 15(6):747-51. PubMed ID: 11371689
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Time course of cerebrospinal fluid responses to antiretroviral therapy: evidence for variable compartmentalization of infection.
    Staprans S; Marlowe N; Glidden D; Novakovic-Agopian T; Grant RM; Heyes M; Aweeka F; Deeks S; Price RW
    AIDS; 1999 Jun; 13(9):1051-61. PubMed ID: 10397535
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Viral and inflammatory markers in cerebrospinal fluid of patients with HIV-1-associated neurocognitive impairment during antiretroviral treatment switch.
    Tiraboschi JM; Muñoz-Moreno JA; Puertas MC; Alonso-Villaverde C; Prats A; Ferrer E; Rozas N; Maso M; Ouchi D; Martinez-Picado J; Podzamczer D
    HIV Med; 2015 Jul; 16(6):388-92. PubMed ID: 25721471
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Proteomic analysis of cerebrospinal fluid extracellular vesicles reveals synaptic injury, inflammation, and stress response markers in HIV patients with cognitive impairment.
    Guha D; Lorenz DR; Misra V; Chettimada S; Morgello S; Gabuzda D
    J Neuroinflammation; 2019 Dec; 16(1):254. PubMed ID: 31805958
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Peripheral and cerebrospinal fluid immune activation and inflammation in chronically HIV-infected patients before and after virally suppressive combination antiretroviral therapy (cART).
    Merlini E; Iannuzzi F; Calcagno A; Bai F; Trunfio M; d'Arminio Monforte A; Bonora S; Marchetti G
    J Neurovirol; 2018 Dec; 24(6):679-694. PubMed ID: 29987585
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Minocycline inhibits oxidative stress and decreases in vitro and in vivo ischemic neuronal damage.
    Morimoto N; Shimazawa M; Yamashima T; Nagai H; Hara H
    Brain Res; 2005 May; 1044(1):8-15. PubMed ID: 15862784
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CSF quinolinic acid levels are determined by local HIV infection: cross-sectional analysis and modelling of dynamics following antiretroviral therapy.
    Valle M; Price RW; Nilsson A; Heyes M; Verotta D
    Brain; 2004 May; 127(Pt 5):1047-60. PubMed ID: 15013955
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Associative and predictive biomarkers of dementia in HIV-1-infected patients.
    Bandaru VV; McArthur JC; Sacktor N; Cutler RG; Knapp EL; Mattson MP; Haughey NJ
    Neurology; 2007 May; 68(18):1481-7. PubMed ID: 17470750
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Minocycline attenuates cognitive impairment and restrains oxidative stress in the hippocampus of rats with chronic cerebral hypoperfusion.
    Cai ZY; Yan Y; Sun SQ; Zhang J; Huang LG; Yan N; Wu F; Li JY
    Neurosci Bull; 2008 Oct; 24(5):305-13. PubMed ID: 18839024
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.